These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12878331)

  • 21. [FMRP immunodetection on hair roots: application to the diagnosis of fragile X syndrome].
    Rifé Soler M; Sánchez Díaz A; Ramos F; Milà Recasens M
    An Pediatr (Barc); 2003 Nov; 59(5):431-5. PubMed ID: 14588214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique.
    Willemsen R; Smits A; Mohkamsing S; van Beerendonk H; de Haan A; de Vries B; van den Ouweland A; Sistermans E; Galjaard H; Oostra BA
    Hum Genet; 1997 Mar; 99(3):308-11. PubMed ID: 9050914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A step-wise diagnosis of fragile X syndrome in Taiwan.
    Huang YT; Chiang SC; Tzeng CC; Liu CH; Chien YH; Hwu WL
    Acta Paediatr Taiwan; 2004; 45(2):69-72. PubMed ID: 15335113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragile X mental retardation protein in plasticity and disease.
    Todd PK; Malter JS
    J Neurosci Res; 2002 Dec; 70(5):623-30. PubMed ID: 12424729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragile X mental retardation: misregulation of protein synthesis in the developing brain?
    Feng Y
    Microsc Res Tech; 2002 May; 57(3):145-7. PubMed ID: 12112449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applicability of a checklist for clinical screening of the fragile X syndrome.
    Arvio M; Peippo M; Simola KO
    Clin Genet; 1997 Oct; 52(4):211-5. PubMed ID: 9383025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles.
    Khandjian EW; Huot ME; Tremblay S; Davidovic L; Mazroui R; Bardoni B
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13357-62. PubMed ID: 15329415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid antibody test for prenatal diagnosis of fragile X syndrome on amniotic fluid cells: a new appraisal.
    Willemsen R; Los F; Mohkamsing S; van den Ouweland A; Deelen W; Galjaard H; Oostra B
    J Med Genet; 1997 Mar; 34(3):250-1. PubMed ID: 9132500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo.
    Todd PK; Mack KJ
    Brain Res Mol Brain Res; 2000 Aug; 80(1):17-25. PubMed ID: 11039725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular studies in fragile X patients with a Prader-Willi-like phenotype.
    de Vries BB; Fryns JP; Butler MG; Canziani F; Wesby-van Swaay E; van Hemel JO; Oostra BA; Halley DJ; Niermeijer MF
    J Med Genet; 1993 Sep; 30(9):761-6. PubMed ID: 8411072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis and screening of fragile X syndrome: experiences in Taiwan.
    Lin SJ
    Acta Paediatr Taiwan; 2004; 45(2):67-8. PubMed ID: 15335112
    [No Abstract]   [Full Text] [Related]  

  • 32. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes.
    Darnell JC; Fraser CE; Mostovetsky O; Stefani G; Jones TA; Eddy SR; Darnell RB
    Genes Dev; 2005 Apr; 19(8):903-18. PubMed ID: 15805463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: a putative animal model of the human fragile X mental retardation syndrome.
    Gruss M; Braun K
    Neural Plast; 2001; 8(4):285-98. PubMed ID: 12018775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Twin sisters, monozygotic with the fragile X mutation, but with a different phenotype.
    Willemsen R; Olmer R; De Diego Otero Y; Oostra BA
    J Med Genet; 2000 Aug; 37(8):603-4. PubMed ID: 10922388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A fragile X case with an amplification/deletion mosaic pattern.
    García Arocena D; de Diego Y; Oostra BA; Willemsen R; Mirta Rodriguez M
    Hum Genet; 2000 Mar; 106(3):366-9. PubMed ID: 10798369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Fragile X mental retardation protein.
    Bardoni B; Schenck A; Mandel JL
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):375-82. PubMed ID: 11719275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into fragile X syndrome: from molecules to neurobehaviors.
    Jin P; Warren ST
    Trends Biochem Sci; 2003 Mar; 28(3):152-8. PubMed ID: 12633995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promiscuous or discriminating: Has the favored mRNA target of Fragile X Mental Retardation Protein been overlooked?
    McMahon AC; Rosbash M
    Proc Natl Acad Sci U S A; 2016 Jun; 113(26):7009-11. PubMed ID: 27317743
    [No Abstract]   [Full Text] [Related]  

  • 39. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting fragile X.
    Gantois I; Kooy RF
    Genome Biol; 2002; 3(5):reviews1014. PubMed ID: 12049671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.